Summary
Hiroshi Yamaguchi is a life sciences executive who bridges advanced cell & gene therapy science with real-world execution, scaling organizations across Japan, the US, China and Europe. As Head of Global Life Sciences at Greenstaff (ICG Medical Group) he founded and scaled the world’s first execution-based CGT talent platform, aligning translational research, CMC, manufacturing strategy and BD to accelerate bench-to-bedside programs. Over 11+ years he has launched and grown life-science operations for multiple multinationals, including establishing Proclinical’s Japan subsidiary and leading APAC market entry efforts. He partners regularly with VCs, CDMOs, academic institutions and pharma to design pragmatic organizational and cost structures that make advanced therapies commercially viable. Known for prioritizing “designs and teams that finish” over technology alone, he’s a sought-after advisor and speaker who combines deep domain networks with hands-on scaling experience. Open to collaborations in partnerships, investment, and talent for CGT and regenerative medicine.
11 years of coding experience
7 years of employment as a software developer
English, Japanese